Potassium%252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCL) is an essential electrolyte that plays a vital role in nerve impulse transmission, muscle contraction, and maintaining acid-base balance. It is available in various formulations, including oral tablets, capsules, liquids, and intravenous solutions. ## Primary Indications * Treatment and prevention of hypokalemia. * Adjunctive therapy in digitalis intoxication. ## Adult Dosing Dosing is highly individualized and depends on the severity of hypokalemia, serum potassium levels, and the patient's clinical status. * **Prevention of Hypokalemia:** Typically 20 mEq (1-2 g elemental potassium) per day, divided into 1-2 doses. * **Treatment of Hypokalemia:** * Oral: 40-100 mEq (2-5 g elemental potassium) per day, divided into 2-4 doses. Maximum daily oral dose generally **100-150 mEq** (5-7.5 g elemental potassium) but may be higher under close monitoring. * Intravenous: Dosing depends on serum potassium levels and clinical condition. Specific protocols are often followed. Generally, initial doses range from 10-20 mEq given over 1-2 hours. **Maximum infusion rates typically should not exceed 10-20 mEq/hour** unless in a life-threatening situation with continuous cardiac monitoring, where rates up to 40 mEq/hour may be used cautiously. **Concentrations for IV administration should not exceed 40 mEq/L (or 60 mEq/L in specific critical care settings)** to reduce the risk of phlebitis and extravasation. **Maximum single IV doses are typically 40 mEq**, but total daily doses can range from 100-400 mEq. ## Pediatric Dosing Dosing is based on age, weight, and serum potassium levels. * **Prevention of Hypokalemia:** 1-2 mEq/kg/day, not to exceed adult maximums. * **Treatment of Hypokalemia:** 2-5 mEq/kg/day, divided into 2-4 doses. Maximum daily oral dose generally **100 mEq**. * **Intravenous:** Dosing is highly individualized and guided by serum potassium levels and ECG. Protocols vary significantly; consult pediatric critical care guidelines. Generally, **maximum infusion rate is 0.5-1 mEq/kg/hour (up to 20 mEq/hour)**. **Maximum concentration is typically 40 mEq/L**. ## Dose Adjustments * **Renal Impairment:** Use with extreme caution. Dose reduction is necessary, and close monitoring of serum potassium is critical. * **Adrenal Insufficiency:** May increase risk of hyperkalemia. ## Contraindications * Hyperkalemia (serum potassium > 5.0 mEq/L). * Conditions that may predispose to hyperkalemia, such as untreated Addison's disease, severe renal impairment, or anuria. * Certain medications that cause hyperkalemia (see drug interactions). * Known hypersensitivity to potassium chloride. ## Adverse Effects * **Gastrointestinal:** Nausea, vomiting, diarrhea, abdominal pain, dysphagia, esophageal irritation or obstruction, gastric perforation. * **Cardiovascular:** Arrhythmias, cardiac arrest (especially with rapid IV administration or hyperkalemia). * **Neuromuscular:** Muscle weakness, paresthesias, paralysis. * **Other:** Hyperkalemia. ## Key Drug Interactions * **ACE Inhibitors, Angiotensin Receptor Blockers (ARBs), Aldosterone Antagonists (e.g., spironolactone, eplerenone), Potassium-sparing diuretics (e.g., amiloride, triamterene), NSAIDs, Heparin, Trimethoprim:** Increase the risk of hyperkalemia. * **Digoxin:** Hyperkalemia may decrease the efficacy of digoxin; hypokalemia may increase the risk of digoxin toxicity. * **Beta-blockers:** May potentiate the risk of hyperkalemia. * **Choline Salicylate:** Concurrent use may increase the risk of hypokalemia. ## Monitoring * **Serum Potassium Levels:** Essential for efficacy and safety. Frequency depends on route of administration, dose, and clinical status. * **Renal Function (BUN, Creatinine):** Especially important in patients with impaired renal function. * **ECG:** Particularly important with IV administration or in patients with risk factors for arrhythmias. * **Signs and Symptoms of Hypokalemia/Hyperkalemia:** Muscle weakness, fatigue, arrhythmias, confusion. ## Clinical Pearls * Oral formulations can cause gastrointestinal irritation. Taking with food or a large glass of water may help. * Extended-release formulations are designed to minimize GI irritation. * Intravenous potassium should always be diluted and administered with caution due to the risk of cardiac arrest. * Never administer IV potassium as a bolus. * Always verify IV potassium concentrations and infusion rates against institutional protocols. *** **Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and institutional protocols before administering any medication.